Experts say Neurocrine Biosciences’ newly approved Prader-Willi syndrome drug may be linked to a series of patient deaths.
A family sues OpenAI, alleging ChatGPT gave deadly drug-use advice, highlighting legal risk for AI providers after a GPT-4o update.